Moroni R F, Inverardi F, Regondi M C, Watakabe A, Yamamori T, Spreafico R, Frassoni C
Unit of Clinical Epileptology and Experimental Neurophysiology, Fondazione I.R.C.C.S., Istituto Neurologico "C. Besta," Via Celoria 11, 20133 Milan, Italy.
Neuroscience. 2009 Mar 17;159(2):682-91. doi: 10.1016/j.neuroscience.2008.12.064. Epub 2009 Jan 10.
The experimental model of cortical dysplasia (CD) obtained by administering carmustine (1-3-bis-chloroethyl-nitrosurea [BCNU]) in pregnant rat uterus mimics the histopathological abnormalities observed in human CD patients: altered cortical layering, and presence of heterotopia and dysmorphic/heterotopic neurons. To investigate further the cortical layering disruption and the neuronal composition of heterotopia in BCNU-exposed cortex, we analyzed the expression pattern of the transcription factors Nurr1, Er81, Ror-beta, and Cux2 (respectively specific markers of layers VI, V, IV and superficial layers) in the cortical areas of BCNU-treated rats by means of in situ hybridization, and compared the findings with those observed in adult control rats. Combining in situ hybridization and immunohistochemistry we also investigated the origin of dysmorphic or heterotopic neurons. The main results of the present study are (i) the analysis of cortical layer thickness revealed that the cortical thinning in the BCNU model was prevalently restricted to the superficial layers; (ii) in cortical and periventricular heterotopia, the prevalent presence of superficial layer neurons in the internal areas, and deeper layer neurons in a more peripheral region, demonstrated a rudimentary pattern of laminar organization in nodule formation; and (iii) the Er81 signal in the dysmorphic and heterotopic pyramidal neurons located in layers I/II showed that they belong to layer V. These results shed light on the disorganization of the laminar architecture of the BCNU model by providing correlations with normal cortical layering and revealing the ontogenesis of heterotopia and heterotopic/dysmorphic neurons. They also provide strong evidence of the usefulness of layer-specific markers in investigating the neuropathology of CD, thus opening up the possibility of expanding their application to human neuropathology.
通过在怀孕大鼠子宫内注射卡莫司汀(1,3-双(氯乙基)-亚硝基脲[BCNU])获得的皮质发育异常(CD)实验模型,模拟了在人类CD患者中观察到的组织病理学异常:皮质分层改变、异位症以及发育异常/异位神经元的存在。为了进一步研究BCNU暴露皮质中的皮质分层破坏和异位症的神经元组成,我们通过原位杂交分析了BCNU处理大鼠皮质区域中转录因子Nurr1、Er81、Ror-β和Cux2(分别为VI、V、IV层和浅层的特异性标志物)的表达模式,并将结果与成年对照大鼠中观察到的结果进行比较。结合原位杂交和免疫组织化学,我们还研究了发育异常或异位神经元的起源。本研究的主要结果如下:(i)皮质层厚度分析显示,BCNU模型中的皮质变薄主要局限于浅层;(ii)在皮质和脑室周围异位症中,内部区域普遍存在浅层神经元,而更外围区域存在深层神经元,这表明在结节形成过程中存在基本的分层组织模式;(iii)位于I/II层的发育异常和异位锥体神经元中的Er81信号表明它们属于V层。这些结果通过与正常皮质分层提供相关性并揭示异位症以及异位/发育异常神经元的个体发生,阐明了BCNU模型中层状结构的紊乱。它们还为层特异性标志物在研究CD神经病理学中的有用性提供了有力证据,从而开辟了将其应用扩展到人类神经病理学的可能性。